Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
Moustafa Ghanem(University of Genoa), Francesco Piacente(University of Genoa), Santina Bruzzone(University of Genoa), Michele Cea(Azienda Ospedaliera S.Maria), Nadia Bertola(University of Genoa), Aimable Nahimana(University of Lausanne), Fiammetta Monacelli(Ospedale Policlinico San Martino), Irene Caffa(Ospedale Policlinico San Martino), Silvia Ravera(Ospedale Policlinico San Martino), Jorge Franco(Innova (Italy)), Alberto Del Río(Institute of Organic Synthesis and Photoreactivity), A. Khalifa(Ospedale Policlinico San Martino), Alessio Nencioni(Ospedale Policlinico San Martino), Michel A. Duchosal(Scripps Health), Marco Parenti(University of Milano-Bicocca)
Cited by 20
Related Papers
Pharmacologic Rescue of Impaired Cognitive Flexibility, Social Deficits, Increased Aggression, and Seizure Susceptibility in Oxytocin Receptor Null Mice: A Neurobehavioral Model of Autism
|Biological Psychiatry|2011|376
G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?
|Journal of Molecular Endocrinology|2004|360
Slc12a8 is a nicotinamide mononucleotide transporter
|Nature Metabolism|2018|279
The Na<sup>+</sup>-P<sub>i</sub>cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary P<sub>i</sub>
|American Journal of Physiology-Renal Physiology|2008|172